erythrosine has been researched along with piroxicam in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anis, HH; Bahgat, M; Farahat, HG; Khoobehi, B; Parry, GJ; Peyman, GA | 1 |
| Asselin, I; Célestin, F; Entman, M; Goulet, M; Guérette, B; Huard, C; Roy, B; Roy, R; Skuk, D; Tardif, F; Tremblay, JP | 1 |
| Hui, SW; Murthy, SN; Sen, A; Zhao, YL | 1 |
| Ciobanu, M; Frisch, B; Heurtault, B; Muller, CD; Ruhlmann, C; Schultz, P | 1 |
4 other study(ies) available for erythrosine and piroxicam
| Article | Year |
|---|---|
Effect of piroxicam on the blood-retina barrier in experimentally induced diabetes in rats.
Topics: Animals; Blood-Retinal Barrier; Cataract; Diabetes Mellitus, Experimental; Fluorescein; Fluoresceins; Fluorophotometry; Male; Piroxicam; Rats; Streptozocin; Vitreous Body | 1991 |
Prevention by anti-LFA-1 of acute myoblast death following transplantation.
Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Apoptosis; beta-Galactosidase; Biomarkers; Cell Adhesion; Cell Death; Cell Line, Transformed; Fluoresceins; Genes, Reporter; Graft Rejection; Immunosuppressive Agents; Inflammation; Interleukin-1; Lymphocyte Function-Associated Antigen-1; Macrophage-1 Antigen; Methylprednisolone; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred mdx; Mice, SCID; Muscle, Skeletal; Muscular Dystrophy, Animal; Naproxen; Necrosis; Neutrophils; Oxidative Stress; Peroxidase; Piroxicam; Radiation Chimera; Stem Cell Transplantation; Tacrolimus; Whole-Body Irradiation; Zymosan | 1997 |
Cyclodextrin enhanced transdermal delivery of piroxicam and carboxyfluorescein by electroporation.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Administration, Cutaneous; Animals; beta-Cyclodextrins; Biological Transport; Diffusion; Drug Carriers; Electroporation; Fluoresceins; Piroxicam; Skin; Skin Absorption; Surface-Active Agents; Swine | 2004 |
Layersome: development and optimization of stable liposomes as drug delivery system.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cations; Cholesterol; Cryoelectron Microscopy; Drug Compounding; Drug Delivery Systems; Drug Stability; Fluoresceins; Fluorescent Dyes; Liposomes; Permeability; Phosphatidylcholines; Phosphatidylglycerols; Piroxicam; Polyglutamic Acid; Polylysine; Static Electricity | 2007 |